Feasibility Study of Deep Learning-based MDixon Quant for Quantitative Assessment of Chemotherapy-induced Fatty Liver
Status:
RECRUITING
Trial end date:
2024-12-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to quantitatively assess the changes in liver fat content in cancer patients before and after treatment.
The main questions it aims to answer are:How does the liver fat fraction change before and after chemotherapy? In this study, patients undergoing mDixon Quant scanning are subjected to fully automated segmentation and measurement of liver fat content using artificial intelligence.